Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Apr 11;15(1):41.
doi: 10.1186/1465-9921-15-41.

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis

Affiliations
Editorial

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis

Tavs Qvist et al. Respir Res. .

Abstract

Important paradigms of pulmonary disease with nontuberculous mycobacteria (NTM) are currently shifting based on an increasing attention within the field of cystic fibrosis (CF). These shifts are likely to benefit the management of all patients with pulmonary NTM, regardless of underlying pathology. Currently several key areas are being revised: The first outbreak of human NTM transmission has been proven and new evidence of biofilm growth in vivo has been demonstrated. A better understanding of the clinical impact of NTM infection has led to increased diagnostic vigilance and new recommendations for lung transplantation are under way. While recent changes have reinvigorated the interest in NTM disease, the challenge remains, whether such advances can be successfully translated into improved management and care.

PubMed Disclaimer

References

    1. Torrens JK, Dawkins P, Conway SP, Moya E. Non-tuberculous mycobacteria in cystic fibrosis. Thorax. 1998;53(0040–6376 (Print)):182–185. - PMC - PubMed
    1. Griffith DE, Aksamit T, Brown-Elliott B a, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K, Wallace RJ Jr. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. doi: 10.1164/rccm.200604-571ST. - DOI - PubMed
    1. El HG, Viola GM, Hachem R, Han XY, Raad II. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis. 2013;13(1474–4457 (Electronic)):166–174. - PubMed
    1. Kulka K, Hatfull G, Ojha AK. Growth of Mycobacterium tuberculosis Biofilms. J Vis Exp. 2012;60(60):e3820. doi:10.3791/3820. - PMC - PubMed
    1. Qvist T, Eickhardt-Sørensen S, Pressler T, Katzenstein TL, Andersen CB, Iversen M, Bjarnsholt T, Hoiby N. First evidence of Mycobacterium abscessus biofilm in the lungs of chronically infected CF patients. J Cyst Fibros. 2013;12(Suppl. 1):S2–S2.

Publication types

MeSH terms

Substances